RxDoctor Payments Data

Hannah Horton

Physician Assistant · Springfield, ORNPI 1245814508

Payments from drug & device makers

$707in general payments, 2019–2025

Across 35 payments — averaging $20.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Edwards Lifesciences$126
  • Bristol Myers Squibb$94
  • Novartis$91
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$74
  • E.r. Squibb & Sons, L.L.C.$59
  • Teleflex LLC$48
  • plus $215 from 8 others

What the payments were for

  • Food & beverage$707100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$707 in reported general payments places this provider in the 75th percentile of 1,756 physician assistant providers in Oregon.

See all physician assistant providers in Oregon

Medicare billing

Part B allowed, 2024
$36,296
Medicare patients
217
Services billed
449

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban194$222,964
FarxigaDapagliflozin Propanediol29$26,227
XareltoRivaroxaban21$19,183
JardianceEmpagliflozin20$19,093
Repatha SureclickEvolocumab11$7,406
Metoprolol Succinate184$2,785
Rosuvastatin Calcium178$2,563
Ezetimibe71$2,453
Valsartan96$2,097
Atorvastatin Calcium92$1,319
Amlodipine Besylate105$1,112
Torsemide60$1,092
Carvedilol81$1,028
Verapamil ErVerapamil Hcl11$969
Irbesartan21$912

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$14$222,964194 claims
AstraZenecaFarxiga$31$26,22729 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,756 physician assistant providers in Oregon.

Other physician assistant in Springfield

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →